<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress.com" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
	xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
	>
<url><loc>https://blog.lifesciencenation.com/2026/04/07/technical-risk-from-belief-to-evidence/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-07T12:48:03+00:00</news:publication_date><news:title>Technical Risk &#8211; From Belief to Evidence </news:title><news:keywords>venture capital, Healthcare, news, science, technology, startups, marketing, health, AI, business, entrepreneurship, finance, investing, artificial-intelligence, digital-marketing, chatgpt</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/04/07/how-early-stage-companies-should-think-about-june-in-san-diego/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-07T12:48:01+00:00</news:publication_date><news:title>How Early-Stage Companies Should Think About June in San Diego </news:title><news:keywords>venture capital, technology, startups, business, entrepreneurship, finance</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/04/07/extend-your-reach-across-two-key-life-science-markets/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-07T12:47:56+00:00</news:publication_date><news:title>Extend Your Reach Across Two Key Life Science Markets </news:title><news:keywords>venture capital, startup, technology, startups, marketing, business, entrepreneurship</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/04/07/hot-investor-mandate-global-corporate-venture-capital-firm-invests-in-therapeutics-from-seed-to-ipo-stages-focusing-on-us-based-companies/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-07T12:31:00+00:00</news:publication_date><news:title>Hot Investor Mandate: Global Corporate Venture Capital Firm Invests in Therapeutics from Seed to IPO Stages, Focusing on US-Based Companies</news:title><news:keywords>technology, health, business, entrepreneurship, finance, investing</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/04/07/hot-investor-mandate-venture-formation-and-investment-firm-seeks-innovative-therapeutics-with-strong-interests-in-small-molecule-oncology/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-07T12:31:00+00:00</news:publication_date><news:title>Hot Investor Mandate: Venture Formation and Investment Firm Seeks Innovative Therapeutics, With Strong Interests in Small Molecule Oncology  </news:title><news:keywords>technology, health, business, finance, investing</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/04/07/hot-investor-mandate-multi-stage-global-healthcare-platform-with-strong-china-commercialization-capabilities-invests-in-therapeutics-devices-healthcare-services/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-07T12:31:00+00:00</news:publication_date><news:title>Hot Investor Mandate: Multi-Stage Global Healthcare Platform with Strong China Commercialization Capabilities Invests in Therapeutics, Devices, Healthcare Services </news:title><news:keywords>technology, health, business, finance, investing</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/04/07/hot-investor-mandate-private-investment-firm-invests-2-6m-in-early-clinical-stage-therapeutics-medical-device-and-diagnostics-companies-based-in-the-us/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-07T12:31:00+00:00</news:publication_date><news:title>Hot Investor Mandate: Private Investment Firm Invests $2-6M in Early Clinical-Stage Therapeutics, Medical Device, and Diagnostics Companies Based in the US</news:title><news:keywords>technology, health, business, finance, investing</news:keywords></news:news></url></urlset>
